EMEA-002407-PIP01-18
Key facts
| Active substance |
Lentiviral vector containing the human ABCA4 gene
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0213/2019
|
| PIP number |
EMEA-002407-PIP01-18
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of inherited retinal disorders
|
| Route(s) of administration |
Intraocular use
|
| Contact for public enquiries |
Sanofi-Aventis Recherche & Développement (France)
Tel.: +31 202454000 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|